Masimo Corporation

NasdaqGS:MASI Stock Report

Market Cap: US$7.9b

Masimo Future Growth

Future criteria checks 3/6

Masimo's revenue is forecast to decline at 2.1% per annum while its annual earnings are expected to grow at 44.4% per year. EPS is expected to grow by 47.4% per annum.

Key information

44.4%

Earnings growth rate

47.35%

EPS growth rate

Medical Equipment earnings growth13.3%
Revenue growth rate-2.1%
Future return on equityn/a
Analyst coverage

Good

Last updated05 Nov 2025

Recent future growth updates

Recent updates

Is Masimo Corporation (NASDAQ:MASI) Potentially Undervalued?

Sep 12
Is Masimo Corporation (NASDAQ:MASI) Potentially Undervalued?

Calculating The Fair Value Of Masimo Corporation (NASDAQ:MASI)

Aug 01
Calculating The Fair Value Of Masimo Corporation (NASDAQ:MASI)

Masimo Corporation: A Much Cleaner Picture

Jun 23

Is Masimo (NASDAQ:MASI) Using Too Much Debt?

Jun 19
Is Masimo (NASDAQ:MASI) Using Too Much Debt?

Is It Time To Consider Buying Masimo Corporation (NASDAQ:MASI)?

May 29
Is It Time To Consider Buying Masimo Corporation (NASDAQ:MASI)?

Masimo: Priced Dearly Given Uncertainty

Apr 25

Pinning Down Masimo Corporation's (NASDAQ:MASI) P/S Is Difficult Right Now

Apr 24
Pinning Down Masimo Corporation's (NASDAQ:MASI) P/S Is Difficult Right Now

An Intrinsic Calculation For Masimo Corporation (NASDAQ:MASI) Suggests It's 34% Undervalued

Feb 17
An Intrinsic Calculation For Masimo Corporation (NASDAQ:MASI) Suggests It's 34% Undervalued

At US$178, Is Masimo Corporation (NASDAQ:MASI) Worth Looking At Closely?

Jan 30
At US$178, Is Masimo Corporation (NASDAQ:MASI) Worth Looking At Closely?

Masimo: A Stellar Performance After The Dust Has Settled

Dec 11

Here's Why Masimo (NASDAQ:MASI) Has A Meaningful Debt Burden

Nov 28
Here's Why Masimo (NASDAQ:MASI) Has A Meaningful Debt Burden

Masimo Corporation: Too Much Uncertainty For Now

Sep 25
User avatar

Sensors Surge And Decisive Shifts Set To Soar In Healthcare Triumph

Increased hospital admissions and successful hospital conversions to Masimo products are anticipated to continue driving healthcare revenue growth.

Masimo: Promising Developments

May 12

Baron Funds - Masimo Corp.: Can Potentially Double Our Investment

May 05

Earnings and Revenue Growth Forecasts

NasdaqGS:MASI - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20271,747295N/AN/A8
12/31/20261,624256356N/A8
12/31/20251,521210345N/A8
9/27/20252,182-240168208N/A
6/28/20252,154-270134177N/A
3/29/20252,127-290137182N/A
12/28/20242,094-305145196N/A
9/28/20241,576115171223N/A
6/29/20241,711101125190N/A
3/30/20241,8239259140N/A
12/30/20232,04882694N/A
9/30/20232,11689-5810N/A
7/1/20232,187116-2828N/A
4/1/20232,297118-457N/A
12/31/20222,036144-2729N/A
10/1/20221,74617178134N/A
7/2/20221,505191147205N/A
4/2/20221,244223181229N/A
1/1/20221,239230230265N/A
10/2/20211,207232188232N/A
7/3/20211,177224149190N/A
4/3/20211,173229176228N/A
1/2/20211,144240131211N/A
9/26/20201,096223138217N/A
6/27/20201,047222148227N/A
3/28/2020976211119222N/A
12/28/2019938196149222N/A
9/28/2019913190150215N/A
6/29/2019895198N/A212N/A
3/30/2019877197N/A210N/A
12/29/2018858194N/A240N/A
9/29/2018843139N/A225N/A
6/30/2018826118N/A199N/A
3/31/2018807119N/A114N/A
12/30/2017790125N/A56N/A
9/30/2017766348N/A338N/A
7/1/2017740340N/A347N/A
4/1/2017720325N/A414N/A
12/31/2016713311N/A419N/A
10/1/2016672109N/A150N/A
7/2/2016657101N/A145N/A
4/2/201664090N/A117N/A
1/2/201662383N/A117N/A
10/3/201562380N/A85N/A
7/4/201561376N/A86N/A
4/4/201559670N/A91N/A
1/3/201558073N/A96N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MASI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.3%).

Earnings vs Market: MASI is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: MASI is expected to become profitable in the next 3 years.

Revenue vs Market: MASI's revenue is expected to decline over the next 3 years (-2.1% per year).

High Growth Revenue: MASI's revenue is forecast to decline over the next 3 years (-2.1% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MASI's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/12 04:37
End of Day Share Price 2025/11/12 00:00
Earnings2025/09/27
Annual Earnings2024/12/28

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Masimo Corporation is covered by 22 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael PolarkBaird
Charley JonesBarrington Research Associates, Inc.
Ravi MisraBerenberg